MACLEODS PHARMS LTD FDA Approval ANDA 213826

ANDA 213826

MACLEODS PHARMS LTD

FDA Drug Application

Application #213826

Application Sponsors

ANDA 213826MACLEODS PHARMS LTD

Marketing Status

Prescription001

Application Products

001OINTMENT;TOPICAL100,000 UNITS/GM0NYSTATINNYSTATIN

FDA Submissions

UNKNOWN; ORIG1AP2021-01-14STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAT

CDER Filings

MACLEODS PHARMS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213826
            [companyName] => MACLEODS PHARMS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"NYSTATIN","activeIngredients":"NYSTATIN","strength":"100,000 UNITS\/GM","dosageForm":"OINTMENT;TOPICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/14\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-01-14
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.